These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 401739)

  • 1. Behaviour of glibenclamide on repeated administration to diabetic patients.
    Balant L; Zahnd GR; Weber F; Fabre J
    Eur J Clin Pharmacol; 1977; 11(1):19-25. PubMed ID: 401739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved effect of glibenclamide on administration before breakfast.
    Sartor G; Lundquist I; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):403-8. PubMed ID: 6804245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Diabetologia; 1980 Jan; 18(1):17-22. PubMed ID: 6767639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.
    Matsuda A; Kuzuya T; Sugita Y; Kawashima K
    Horm Metab Res; 1983 Sep; 15(9):425-8. PubMed ID: 6416980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interindividual variation in the absorption of glibenclamide in man.
    Ikegami H; Shima K; Tanaka A; Tahara Y; Hirota M; Kumahara Y
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):528-32. PubMed ID: 3085419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [14C-Glibenclamide concentrations in serum and 14C-glibenclamide urine excretion in diabetic patients with simultaneous determination of blood glucose and insulin (author's transl)].
    Birk W; Schmidt HA; Petrides P
    Arzneimittelforschung; 1978; 28(2):330-7. PubMed ID: 416832
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapancreatic insulin effect of glibenclamide.
    Mulder H; Schopman W; van der Lely AJ
    Eur J Clin Pharmacol; 1991; 40(4):379-81. PubMed ID: 1904820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.
    Rogers HJ; Spector RG; Morrison PJ; Bradbrook ID
    Diabetologia; 1982 Jul; 23(1):37-40. PubMed ID: 6811355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of glibenclamide in oral insulin capsules.
    Singh BM; Wise PH; Marks V
    Lancet; 1991 Aug; 338(8762):308-70. PubMed ID: 1677127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical application of the hypoglycemic agent glibenclamide and changes in blood glucose, plasma insulin (IRI) levels and plasma concentration of glibenclamide in normal rats.
    Yamamoto T; Katakabe K; Akiyoshi K; Kan K; Asano T; Okumura M
    Diabetes Res Clin Pract; 1990 Jan; 8(1):19-22. PubMed ID: 2105197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.
    Rydberg T; Jönsson A; Røder M; Melander A
    Diabetes Care; 1994 Sep; 17(9):1026-30. PubMed ID: 7988301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.